Skip to main content

C167 Pill: white, capsule/oblong, 17mm

The pill with imprint C167 (White, Capsule/Oblong, 17mm) has been identified as Lamivudine 300 mg and is used for Hepatitis B, HIV Infection, Nonoccupational Exposure, and Occupational Exposure. It belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is not a controlled substance.

Images for C167

Lamivudine

Imprint
C167
Strength
300 mg
Color
White
Size
17.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
69097-0167
Inactive Ingredients
hypromellose 2910 (15 mPa.s), magnesium stearate, microcrystalline cellulose, sodium starch glycolate type B potato, polyethylene glycol 6000, corn starch, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.